Scholarlink

<p><i>Candida auris</i> is an emerging multidrug-resistant fungal pathogen posing serious global healthcare challenges due to its persistence, frequent misidentification, and resistance to all major antifungal drugs. This study aimed to explore natural therapeutic alternatives by investigating the antifungal and molecular properties of <i>Moringa peregrina</i> and <i>Moringa oleifera</i> leaf extracts. Ethanolic and aqueous extracts of both <i>Moringa species</i> were prepared and evaluated against <i>C. auris</i> and other <i>Candida species</i> (<i>Candida spp</i>.) using zone of inhibition (ZI), minimum inhibitory concentration (MIC), and minimum fungicidal concentration (MFC) assays. Phytochemical composition was characterized through fourier transform infrared spectroscopy (FTIR) and gas chromatography–mass spectrometry (GC–MS) analyses, while cytotoxicity on mammalian MCF-7 cells was assessed using the MTT assay. Molecular docking and 100-ns molecular dynamics simulations were conducted to examine the binding of key bioactive compounds to <i>C. auris</i> dihydrofolate reductase (DHFR; PDB: 8CRH). Ethanolic extracts exhibited the strongest antifungal activity (ZI: 16–16.5&#xa0;mm; MIC: 0.5–0.7&#xa0;mg/mL), whereas aqueous extracts were comparatively less effective. FTIR spectra revealed prominent peaks corresponding to hydroxyl (O–H), carbonyl (C = O), and C–O functional groups, confirming the presence of alcohols, esters, phenols, and carboxylic acids, while GC–MS identified β-sitosterol, stigmasterol, dihydroxanthin, and vitamin E derivatives as predominant constituents. Docking results revealed high binding affinities for vitamin E (− 86.6&#xa0;kcal/mol) and stigmasterol (− 83.5&#xa0;kcal/mol), exceeding that of fluconazole (− 27.3&#xa0;kcal/mol). Molecular dynamics confirmed stable protein–ligand complexes, with hydrophobic and van der Waals forces dominating the interactions. Cytotoxicity assays revealed low toxicity at antifungal concentrations (IC₅₀ ≥ 120&#xa0;µg/mL). These findings demonstrate that <i>Moringa</i> extracts—particularly the ethanolic fractions—harbor potent bioactive compounds with promising antifungal activity against <i>C. auris</i>, highlighting their potential as novel, plant-derived therapeutic candidates to combat resistant fungal infections.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Comprehensive molecular docking and antifungal activity analysis of Moringa extracts targeting Candida auris dihydrofolate reductase (8CRH)

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月19日

查看全文
  • Maha S. I. Wizrah,
  • Zeinab A. Yahia,
  • Hanan Al-Omari,
  • Norah D. Aldawsari,
  • Ahlam Hamad Alrokban,
  • Nada Ibrahim Alsugiran,
  • Awais Khalid,
  • Rasha Elsayim

摘要

Candida auris is an emerging multidrug-resistant fungal pathogen posing serious global healthcare challenges due to its persistence, frequent misidentification, and resistance to all major antifungal drugs. This study aimed to explore natural therapeutic alternatives by investigating the antifungal and molecular properties of Moringa peregrina and Moringa oleifera leaf extracts. Ethanolic and aqueous extracts of both Moringa species were prepared and evaluated against C. auris and other Candida species (Candida spp.) using zone of inhibition (ZI), minimum inhibitory concentration (MIC), and minimum fungicidal concentration (MFC) assays. Phytochemical composition was characterized through fourier transform infrared spectroscopy (FTIR) and gas chromatography–mass spectrometry (GC–MS) analyses, while cytotoxicity on mammalian MCF-7 cells was assessed using the MTT assay. Molecular docking and 100-ns molecular dynamics simulations were conducted to examine the binding of key bioactive compounds to C. auris dihydrofolate reductase (DHFR; PDB: 8CRH). Ethanolic extracts exhibited the strongest antifungal activity (ZI: 16–16.5 mm; MIC: 0.5–0.7 mg/mL), whereas aqueous extracts were comparatively less effective. FTIR spectra revealed prominent peaks corresponding to hydroxyl (O–H), carbonyl (C = O), and C–O functional groups, confirming the presence of alcohols, esters, phenols, and carboxylic acids, while GC–MS identified β-sitosterol, stigmasterol, dihydroxanthin, and vitamin E derivatives as predominant constituents. Docking results revealed high binding affinities for vitamin E (− 86.6 kcal/mol) and stigmasterol (− 83.5 kcal/mol), exceeding that of fluconazole (− 27.3 kcal/mol). Molecular dynamics confirmed stable protein–ligand complexes, with hydrophobic and van der Waals forces dominating the interactions. Cytotoxicity assays revealed low toxicity at antifungal concentrations (IC₅₀ ≥ 120 µg/mL). These findings demonstrate that Moringa extracts—particularly the ethanolic fractions—harbor potent bioactive compounds with promising antifungal activity against C. auris, highlighting their potential as novel, plant-derived therapeutic candidates to combat resistant fungal infections.